
Thermo Fisher Scientific TMO
$ 473.66
0.78%
Annual report 2025
added 02-26-2026
Thermo Fisher Scientific Historical Prices 2011-2026 | TMO
Annual Historical Prices Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 520 | 539 | 560 | 551 | 544 | 449 | 289 | 258 | 206 | 155 | 127 | 127 | 121 | 71.2 | 54.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 560 | 54.2 | 305 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
9.12 | $ 8.93 | 0.68 % | $ 595 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 13.67 | 0.11 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 25.81 | -0.08 % | $ 717 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
65.4 | $ 67.83 | 2.24 % | $ 26.5 B | ||
|
Guardant Health
GH
|
107 | $ 88.44 | 1.45 % | $ 11.1 B | ||
|
Charles River Laboratories International
CRL
|
155 | $ 153.93 | 1.29 % | $ 7.63 B | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 17.54 | 1.27 % | $ 935 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | $ 103.98 | 0.12 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
IQVIA Holdings
IQV
|
165 | $ 168.58 | 2.24 % | $ 29 B | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 15.54 | 3.95 % | $ 470 M | ||
|
Biodesix
BDSX
|
0.71 | $ 16.96 | -1.91 % | $ 2.2 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 99.21 | 1.63 % | $ 8.18 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.89 | 1.76 % | $ 93.8 K | ||
|
Danaher Corporation
DHR
|
210 | $ 195.14 | 1.96 % | $ 139 B | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.42 | 4.41 % | $ 426 M | ||
|
Illumina
ILMN
|
103 | $ 122.1 | 2.36 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 198.46 | -0.24 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
139 | $ 113.8 | 1.76 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.13 | 1.67 % | $ 1.44 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 9.04 | 7.36 % | $ 256 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 8.31 | 0.85 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.22 | 1.21 % | $ 2 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 80.11 | 2.05 % | $ 5.41 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
449 | $ 457.31 | 0.81 % | $ 13.2 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 218.7 | 1.67 % | $ 25.1 B | ||
|
Celcuity
CELC
|
10.1 | $ 115.13 | 0.2 % | $ 4.54 B | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
14.1 | $ 17.58 | 1.03 % | $ 393 M | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Twist Bioscience Corporation
TWST
|
26.1 | $ 47.21 | 4.89 % | $ 2.82 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
53.9 | $ 199.94 | 1.14 % | $ 19.7 B |